You have free access to this content

Hepatology

Cover image for Vol. 52 Issue 6

December 2010

Volume 52, Issue 6

Pages 1869–2254

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Mining for a diagnosis of Wilson's disease in children: Genetics, score, and ore (pages 1872–1874)

      Richard A. Rosencrantz and Michael L. Schilsky

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24054

    2. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
    2. You have free access to this content
      IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C (pages 1888–1896)

      Thomas J. Urban, Alexander J. Thompson, Shelton S. Bradrick, Jacques Fellay, Detlef Schuppan, Kenneth D. Cronin, Linda Hong, Alexander McKenzie, Keyur Patel, Kevin V. Shianna, John G. McHutchison, David B. Goldstein and Nezam Afdhal

      Version of Record online: 7 OCT 2010 | DOI: 10.1002/hep.23912

    3. You have free access to this content
      Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase? (pages 1897–1905)

      Zhaowen Zhu, Anne T. Wilson, Bruce A. Luxon, Kyle E. Brown, M. Meleah Mathahs, Sarmistha Bandyopadhyay, Anton P. McCaffrey and Warren N. Schmidt

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.23921

    4. You have free access to this content
      Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C (pages 1906–1914)

      Raymond T. Chung, Fred F. Poordad, Tarek Hassanein, Xiaolei Zhou, Ellen Lentz, Avinash Prabhakar and Adrian M. Di Bisceglie

      Version of Record online: 9 NOV 2010 | DOI: 10.1002/hep.23947

    5. You have free access to this content
      Treatment of acute hepatitis C in human immunodeficiency virus–infected patients: The HEPAIG study (pages 1915–1921)

      Lionel Piroth, Christine Larsen, Christine Binquet, Laurent Alric, Isabelle Auperin, Marie-Laure Chaix, Stéphanie Dominguez, Xavier Duval, Anne Gervais, Jade Ghosn, Elisabeth Delarocque-Astagneau and Stanislas Pol

      Version of Record online: 9 NOV 2010 | DOI: 10.1002/hep.23959

    6. You have free access to this content
      Hepatitis B virus–DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma (pages 1922–1933)

      Chau-Ting Yeh, Mary So, Jennifer Ng, Han-Wen Yang, Ming-Ling Chang, Ming-Wei Lai, Tse-Ching Chen, Chun-Yen Lin, Ta-Sen Yeh and Wei-Chen Lee

      Version of Record online: 2 SEP 2010 | DOI: 10.1002/hep.23898

    7. You have free access to this content
      The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function (pages 1934–1947)

      Bijan Raziorrouh, Winfried Schraut, Tilman Gerlach, Daniela Nowack, Norbert H. Grüner, Axel Ulsenheimer, Reinhart Zachoval, Martin Wächtler, Michael Spannagl, Jürgen Haas, Helmut M. Diepolder and Maria-Christina Jung

      Version of Record online: 9 NOV 2010 | DOI: 10.1002/hep.23936

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease (pages 1948–1956)

      Emanuele Nicastro, Giusy Ranucci, Pietro Vajro, Angela Vegnente and Raffaele Iorio

      Version of Record online: 21 OCT 2010 | DOI: 10.1002/hep.23910

    2. You have free access to this content
      Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins (pages 1957–1967)

      Keyang Chen, Ming-Lin Liu, Lana Schaffer, Mingzhen Li, Guenther Boden, Xiangdong Wu and Kevin Jon Williams

      Version of Record online: 3 NOV 2010 | DOI: 10.1002/hep.23916

    3. You have free access to this content
      A protective role for CD154 in hepatic steatosis in mice (pages 1968–1979)

      Julien Villeneuve, Sébastien Lepreux, Audrey Mulot, Annie M. Bérard, Arisa Higa-Nishiyama, Pierre Costet, Victor De Ledinghen, Paulette Bioulac-Sage, Charles Balabaud, Alan T. Nurden, Jean Rosenbaum, Eric Chevet and Jean Ripoche

      Version of Record online: 9 NOV 2010 | DOI: 10.1002/hep.23935

    4. You have free access to this content
      Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease (pages 1980–1991)

      Marcos Martínez-Clemente, Natàlia Ferré, Esther Titos, Raquel Horrillo, Ana González-Périz, Eva Morán-Salvador, Cristina López-Vicario, Rosa Miquel, Vicente Arroyo, Colin D. Funk and Joan Clària

      Version of Record online: 21 OCT 2010 | DOI: 10.1002/hep.23928

    5. You have free access to this content
      Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator–activated receptor γ coactivator 1α promoter (pages 1992–2000)

      Silvia Sookoian, Maria Soledad Rosselli, Carolina Gemma, Adriana L. Burgueño, Tomas Fernández Gianotti, Gustavo O. Castaño and Carlos J. Pirola

      Version of Record online: 1 OCT 2010 | DOI: 10.1002/hep.23927

    6. You have free access to this content
      Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice (pages 2001–2011)

      Anisha A. Gupte, Joey Z. Liu, Yuelan Ren, Laurie J. Minze, Jessica R. Wiles, Alan R. Collins, Christopher J. Lyon, Domenico Pratico, Milton J. Finegold, Stephen T. Wong, Paul Webb, John D. Baxter, David D. Moore and Willa A. Hsueh

      Version of Record online: 11 OCT 2010 | DOI: 10.1002/hep.23941

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma (pages 2012–2022)

      Yu-Hua Xue, Xiao-Fei Zhang, Qiong-Zhu Dong, Jian Sun, Chun Dai, Hai-Jun Zhou, Ning Ren, Hu-Liang Jia, Qin-Hai Ye and Lun-Xiu Qin

      Version of Record online: 1 OCT 2010 | DOI: 10.1002/hep.23942

    2. You have free access to this content
      Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms (pages 2023–2033)

      Benjamin Goeppert, Peter Schmezer, Céline Dutruel, Christopher Oakes, Marcus Renner, Marco Breinig, Arne Warth, Monika Nadja Vogel, Michel Mittelbronn, Arianeb Mehrabi, Georg Gdynia, Roland Penzel, Thomas Longerich, Kai Breuhahn, Odilia Popanda, Christoph Plass, Peter Schirmacher and Michael André Kern

      Version of Record online: 26 OCT 2010 | DOI: 10.1002/hep.23939

    3. You have free access to this content
      Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma (pages 2034–2043)

      Robert J. Clifford, Jinghui Zhang, Daoud M. Meerzaman, Myung-Soo Lyu, Ying Hu, Constance M. Cultraro, Richard P. Finney, Jenny M. Kelley, Sol Efroni, Sharon I. Greenblum, Cu V. Nguyen, William L. Rowe, Sweta Sharma, Gang Wu, Chunhua Yan, Hongen Zhang, Young-Hwa Chung, Jeong A. Kim, Neung Hwa Park, Il Han Song and Kenneth H. Buetow

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.23943

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis (pages 2044–2052)

      Pablo Bellot, Juan Carlos García-Pagán, Rubén Francés, Juan G. Abraldes, Miguel Navasa, Miguel Pérez-Mateo, José Such and Jaime Bosch

      Version of Record online: 26 OCT 2010 | DOI: 10.1002/hep.23918

    2. You have free access to this content
      E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA–dependent Smad3 phosphorylation (pages 2053–2064)

      Il Je Cho, Young Woo Kim, Chang Yeob Han, Eun Hyun Kim, Richard A. Anderson, Young Sok Lee, Chang Ho Lee, Se Jin Hwang and Sang Geon Kim

      Version of Record online: 1 OCT 2010 | DOI: 10.1002/hep.23931

    3. You have free access to this content
    4. You have free access to this content
      Motor-evoked potentials in awake rats are a valid method of assessing hepatic encephalopathy and of studying its pathogenesis (pages 2077–2085)

      Marc Oria, Nicolas Chatauret, Laia Chavarria, Jordi Romero-Giménez, Lluis Palenzuela, Benjamin Pardo-Yules, José Antonio Arranz, Guillermo Bodega, Núria Raguer and Juan Córdoba

      Version of Record online: 1 OCT 2010 | DOI: 10.1002/hep.23938

    5. You have free access to this content
      Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis (pages 2086–2095)

      María Úbeda, Leticia Muñoz, María-José Borrero, David Díaz, Rubén Francés, Jorge Monserrat, Margaret Lario, Lourdes Lledó, José Such, Melchor Álvarez-Mon and Agustín Albillos

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.23961

  7. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice (pages 2096–2108)

      Kwang Suk Ko, Maria Lauda Tomasi, Ainhoa Iglesias-Ara, Barbara A. French, Samuel W. French, Komal Ramani, Juan José Lozano, Pilsoo Oh, Lina He, Bangyan L Stiles, Tony W.H Li, Heping Yang, M. Luz Martínez-Chantar, José M. Mato and Shelly C. Lu

      Version of Record online: 1 OCT 2010 | DOI: 10.1002/hep.23919

    2. You have free access to this content
      Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice (pages 2109–2117)

      Vered Gazit, Alexander Weymann, Eric Hartman, Brian N. Finck, Paul W. Hruz, Anatoly Tzekov and David A. Rudnick

      Version of Record online: 21 OCT 2010 | DOI: 10.1002/hep.23920

    3. You have free access to this content
    4. You have free access to this content
      Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes (pages 2127–2136)

      Sebastian Zellmer, Wolfgang Schmidt-Heck, Patricio Godoy, Honglei Weng, Christoph Meyer, Thomas Lehmann, Titus Sparna, Wiebke Schormann, Seddik Hammad, Clemens Kreutz, Jens Timmer, Fritz von Weizsäcker, Petra A. Thürmann, Irmgard Merfort, Reinhard Guthke, Steven Dooley, Jan G. Hengstler and Rolf Gebhardt

      Version of Record online: 26 OCT 2010 | DOI: 10.1002/hep.23930

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice (pages 2137–2147)

      Xiuying Zhang, Shingo Tachibana, Hua Wang, Masayuki Hisada, George Melville Williams, Bin Gao and Zhaoli Sun

      Version of Record online: 7 OCT 2010 | DOI: 10.1002/hep.23909

    2. You have free access to this content
      miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice (pages 2148–2157)

      Zhipeng Meng, Xianghui Fu, Xiaosong Chen, Samuel Zeng, Yan Tian, Richard Jove, Rongzhen Xu and Wendong Huang

      Version of Record online: 26 OCT 2010 | DOI: 10.1002/hep.23915

    3. You have free access to this content
      Mmp23b promotes liver development and hepatocyte proliferation through the tumor necrosis factor pathway in zebrafish (pages 2158–2166)

      Fei Qi, Jianbo Song, Hanshuo Yang, Wei Gao, Ning-ai Liu, Bo Zhang and Shuo Lin

      Version of Record online: 9 NOV 2010 | DOI: 10.1002/hep.23945

    4. You have free access to this content
      Unconjugated bile salts shuttle through hepatocyte peroxisomes for taurine conjugation (pages 2167–2176)

      Krzysztof P. Rembacz, Jannes Woudenberg, Mark Hoekstra, Elles Z. Jonkers, Fiona A.J. van den Heuvel, Manon Buist-Homan, Titia E. Woudenberg-Vrenken, Jana Rohacova, M. Luisa Marin, Miguel A. Miranda, Han Moshage, Frans Stellaard and Klaas Nico Faber

      Version of Record online: 3 NOV 2010 | DOI: 10.1002/hep.23954

    5. You have free access to this content
  9. Diagnotis and Therapeutic Advances in Hepatology

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Positron emission tomography scan for a hepatic mass (pages 2186–2191)

      Boris Blechacz and Gregory J. Gores

      Version of Record online: 21 OCT 2010 | DOI: 10.1002/hep.24002

  10. Meeting Report

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options (pages 2192–2205)

      Maureen M. Jonas, Joan M. Block, Barbara A. Haber, Saul J. Karpen, W. Thomas London, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Kathleen B. Schwarz and Brian J. McMahon

      Version of Record online: 1 OCT 2010 | DOI: 10.1002/hep.23934

  11. Reviews

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Medical and surgical treatment options for polycystic liver disease (pages 2223–2230)

      Joost P.H. Drenth, Melissa Chrispijn, David M. Nagorney, Patrick S. Kamath and Vicente E. Torres

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24036

  12. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
    2. You have free access to this content
      Teaching New Tricks to an Old Foe: Murinizing Hepatitis C Virus (pages 2233–2236)

      Gisa Gerold, Charles M. Rice and Alexander Ploss

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24045

  13. Image of the Month

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
  14. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
      Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis (page 2240)

      Carole Macaron, Ibrahim A. Hanouneh and Nizar N. Zein

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24005

    2. You have free access to this content
      Reply: (page 2239)

      Albert Parés and Llorenç Caballería

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24035

    3. You have free access to this content
      Proceed with caution: Peginterferon alpha-2a versus peginterferon alfa-2b in chronic hepatitis C. A systematic review of randomized trials (pages 2240–2241)

      David Kershenobich, Linda Muñoz, René Malé, Jesús Gaytan and Francisco Sánchez

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24025

    4. You have free access to this content
      Reply: (page 2241)

      Tahany Awad, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk and Christian Gluud

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24050

    5. You have free access to this content
      Liver enzymes and cardiovascular outcomes: A new research agenda (page 2242)

      Yusuf Yilmaz, Ramazan Kurt and Cem Kalayci

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23825

    6. You have free access to this content
      Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype (pages 2243–2244)

      Alexander J. Thompson, Andrew J. Muir, Mark S. Sulkowski, Keyur Patel, Hans L. Tillmann, Paul J. Clark, Susanna Naggie, Jacques Fellay, Dongliang Ge, Jeanette J. McCarthy, David B. Goldstein and John G. McHutchison

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23826

    7. You have free access to this content
    8. You have free access to this content
      Drug-induced postinfantile giant cell hepatitis (pages 2245–2246)

      Ricardo Moreno-Otero, María Trapero-Marugán, Luisa García-Buey and Asunción García-Sancchez

      Version of Record online: 1 OCT 2010 | DOI: 10.1002/hep.23830

    9. You have free access to this content
      Drug-induced autoimmune hepatitis caused by anti–tumor necrosis factor α agents (pages 2246–2247)

      Cumali Efe, Tugrul Purnak, Ersan Ozaslan and Staffan Wahlin

      Version of Record online: 16 JUL 2010 | DOI: 10.1002/hep.23834

    10. You have free access to this content
      Treatment response in patients with autoimmune hepatitis (pages 2247–2248)

      Christoph Schramm, Christina Weiler-Normann, Christiane Wiegard, Stefanie Hellweg, Susanne Müller and Ansgar W. Lohse

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23840

    11. You have free access to this content
      Nonalcoholic fatty liver in a developing country is responsible for significant liver disease (pages 2248–2249)

      Ajay Duseja, Balkrishan Sharma, Amit Kumar, Shweta Kapil, Ashim Das, Radha K. Dhiman and Yogesh K. Chawla

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23838

  15. Corrections

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content
    2. You have free access to this content
      General information/AASLD Awards (page 2250)

      Version of Record online: 23 NOV 2010 | DOI: 10.1002/hep.24069

      This article corrects:

      General information/AASLD Awards

      Vol. 52, Issue S1Issue Supplement S1, 4A–30A, Version of Record online: 30 SEP 2010

  16. Referees

    1. Top of page
    2. Comments from the Editors
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Diagnotis and Therapeutic Advances in Hepatology
    11. Meeting Report
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Corrections
    17. Referees
    1. You have free access to this content

SEARCH

SEARCH BY CITATION